The pathophysiology of NICTH arises from excessive tumor production of both IGF-II and its precursor “big” IGF-II, resulting in an altered IGF-I to IGF-II ratio and insulin-independent stimulation of the insulin receptor. This evidence concerns the gene IGF2 and neoplasm.